PL366938A1 - Sposób wytwarzania ekstraktu z liści Ginkgo Biloba o wysokiej zawartości składników aktywnych - Google Patents

Sposób wytwarzania ekstraktu z liści Ginkgo Biloba o wysokiej zawartości składników aktywnych

Info

Publication number
PL366938A1
PL366938A1 PL02366938A PL36693802A PL366938A1 PL 366938 A1 PL366938 A1 PL 366938A1 PL 02366938 A PL02366938 A PL 02366938A PL 36693802 A PL36693802 A PL 36693802A PL 366938 A1 PL366938 A1 PL 366938A1
Authority
PL
Poland
Prior art keywords
extract
ginkgo biloba
biloba leaves
ethyl acetate
liquid
Prior art date
Application number
PL02366938A
Other languages
English (en)
Other versions
PL204867B1 (pl
Inventor
Beng-Poon Teng
Original Assignee
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) filed Critical Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)
Publication of PL366938A1 publication Critical patent/PL366938A1/pl
Publication of PL204867B1 publication Critical patent/PL204867B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL366938A 2001-04-10 2002-04-09 Ekstrakt z liści Ginkgo biloba, sposób jego wytwarzania, kompozycja farmaceutyczna zawierająca go i zastosowanie PL204867B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0104942A FR2823116B1 (fr) 2001-04-10 2001-04-10 Procede de preparation d'une extrait de feuilles de ginkgo biloba hautement enrichi en principes actifs

Publications (2)

Publication Number Publication Date
PL366938A1 true PL366938A1 (pl) 2005-02-07
PL204867B1 PL204867B1 (pl) 2010-02-26

Family

ID=8862215

Family Applications (1)

Application Number Title Priority Date Filing Date
PL366938A PL204867B1 (pl) 2001-04-10 2002-04-09 Ekstrakt z liści Ginkgo biloba, sposób jego wytwarzania, kompozycja farmaceutyczna zawierająca go i zastosowanie

Country Status (19)

Country Link
US (1) US7048954B2 (pl)
EP (1) EP1379262B1 (pl)
JP (1) JP4416404B2 (pl)
KR (1) KR100876233B1 (pl)
CN (1) CN1245167C (pl)
AT (1) ATE278411T1 (pl)
AU (1) AU2002307981B2 (pl)
CA (1) CA2443302C (pl)
CZ (1) CZ299652B6 (pl)
DE (1) DE60201525T8 (pl)
DK (1) DK1379262T3 (pl)
ES (1) ES2230512T3 (pl)
FR (1) FR2823116B1 (pl)
HU (1) HUP0303797A3 (pl)
NZ (1) NZ528571A (pl)
PL (1) PL204867B1 (pl)
PT (1) PT1379262E (pl)
RU (1) RU2297235C2 (pl)
WO (1) WO2002083158A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60215671T2 (de) 2001-07-11 2007-09-06 The Trustees Of Columbia University In The City Of New York Verfahren zur isolierung von terpentrilactonen (ginkgoliden, bilobaliden) aus blättern und pharmazeutische pulver aus ginkgo biloba
WO2003082185A2 (en) 2002-03-29 2003-10-09 The Trustees Of Columbia University In The City Of New York Analogs of terpene trilactones from ginkgo biloba and related compounds and uses thereof
JP2004307396A (ja) 2003-04-07 2004-11-04 Kao Corp デオドラント剤
WO2005021496A2 (en) 2003-08-27 2005-03-10 The Trustees Of Columbia University In The City Of New York Synthesis of derivatives of ginkgolide c
WO2005046829A2 (en) 2003-11-12 2005-05-26 The Trustees Of Columbia University In The City Of New York Separation of ginkgolides and bilobalide from g. biloba
EP1537874B1 (de) * 2003-12-04 2007-06-13 Cognis IP Management GmbH Verfahren zur Herstellung von Extrakten des Ginkgo Biloba
WO2006004386A1 (es) * 2004-07-02 2006-01-12 Rojas Castaneda Patricia Uso de un extracto del ginkgo biloba para preparar una medicina para tratar la enfermedad de parkinson
CN1891242B (zh) * 2005-07-06 2012-01-04 徐州技源天然保健品有限公司 一种从银杏叶提取物中脱除多环芳烃的生产工艺
FR2904222A1 (fr) * 2006-07-27 2008-02-01 Sod Conseils Rech Applic Utilisation d4extraits de ginkgo biloba pour le traitement de maladies mitochondriales
CZ299802B6 (cs) * 2006-10-12 2008-11-26 Kalvoda@Jaroslav Príprava zálivky obsahující extrakt z náprstníku cerveného, extrakt z jinanu dvoulalocného a dusicnan draselný, a její vliv na rostliny
HUE041715T2 (hu) * 2007-12-21 2019-05-28 Dr Willmar Schwabe Gmbh & Co Kg Ginkgo biloba levél-kivonat alkalmazása
FR2926994B1 (fr) * 2008-02-06 2010-08-27 Sod Conseils Rech Applic Nouveau procede pour la preparation d'extraits de ginkgo biloba
EP2459205A1 (en) * 2009-07-28 2012-06-06 Velleja Research SRL Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders
CN110893183A (zh) * 2018-09-13 2020-03-20 成都百裕制药股份有限公司 银杏萜内酯在制备预防、缓解或治疗肌萎缩侧索硬化药物中的应用
FR3152724A1 (fr) * 2023-09-13 2025-03-14 Chromavis France Extrait de ginkgo biloba pour stimuler la croissance des cils

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1044659C (zh) * 1987-06-30 1999-08-18 吴羽化学工业株式会社 含有唑类衍生物的农业和园艺用的农药组合物
DE3832056A1 (de) * 1988-09-21 1990-03-22 Scholle Helmut Dr Med Verwendung eines ginkgo-extraktes
JPH02193907A (ja) * 1989-01-19 1990-07-31 Daicel Chem Ind Ltd イチョウエキスの製法
KR940002796B1 (ko) * 1989-06-16 1994-04-02 주식회사 선경인더스트리 은행잎에서 징코라이드를 분리 및 정제하는 방법
DE3940095A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE3940091A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE3940094A1 (de) * 1989-12-04 1991-06-06 Montana Ltd Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel
DE3940092A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
GB9107425D0 (en) * 1991-04-09 1991-05-22 Scras Preparation of ginkgolide b
DE4308443C2 (de) * 1993-03-17 1996-09-19 Laves Hans Georg Arzneimittel zur Behandlung von Retrovirusinfektionen
GB9408044D0 (en) * 1994-04-22 1994-06-15 Sod Conseils Rech Applic Conversion of ginkgolide c to ginkgolide b
DE19756848C2 (de) * 1997-12-19 2003-01-16 Schwabe Willmar Gmbh & Co Extrakte aus Blättern von Ginkgo biloba mit vermindertem Gehalt an 4'-O-Methylpyridoxin und Biflavonen
US6030621A (en) * 1998-03-19 2000-02-29 De Long; Xie Ginkgo biloba composition, method to prepare the same and uses thereof
DE19829516B4 (de) * 1998-07-02 2004-08-26 Dr. Willmar Schwabe Gmbh & Co. Kg Wasserlöslicher nativer Trockenextrakt aus Gingko biloba mit hohem Gehalt an Terpenoiden und Flavonglykosiden
CN1124275C (zh) * 2000-06-02 2003-10-15 天津大学 由银杏叶或银杏叶浸膏制备药物银杏内酯a、b的方法
ATE265858T1 (de) * 2000-06-16 2004-05-15 Linnea Sa Wasserlöslicher komplex eines ginkgo biloba extrakts, verfahren zu dessen herstellung und diesen enthaltende zusammensetzung
DE60215671T2 (de) * 2001-07-11 2007-09-06 The Trustees Of Columbia University In The City Of New York Verfahren zur isolierung von terpentrilactonen (ginkgoliden, bilobaliden) aus blättern und pharmazeutische pulver aus ginkgo biloba
CN1287121C (zh) * 2004-04-05 2006-11-29 广东科龙电器股份有限公司 可实现冷媒充灌量动态控制的空调器节流装置

Also Published As

Publication number Publication date
US20040109907A1 (en) 2004-06-10
KR20030087068A (ko) 2003-11-12
CA2443302C (fr) 2012-09-18
EP1379262B1 (fr) 2004-10-06
AU2002307981B2 (en) 2006-11-23
ES2230512T3 (es) 2005-05-01
PT1379262E (pt) 2005-02-28
CN1501806A (zh) 2004-06-02
RU2297235C2 (ru) 2007-04-20
HUP0303797A2 (hu) 2004-03-29
CZ299652B6 (cs) 2008-10-01
PL204867B1 (pl) 2010-02-26
KR100876233B1 (ko) 2008-12-26
DE60201525T2 (de) 2006-03-02
EP1379262A1 (fr) 2004-01-14
DE60201525D1 (de) 2004-11-11
HK1066164A1 (en) 2005-03-18
CZ20033055A3 (cs) 2004-06-16
US7048954B2 (en) 2006-05-23
NZ528571A (en) 2005-06-24
FR2823116B1 (fr) 2004-11-19
DE60201525T8 (de) 2006-08-24
RU2003132470A (ru) 2005-03-10
CN1245167C (zh) 2006-03-15
JP4416404B2 (ja) 2010-02-17
WO2002083158A1 (fr) 2002-10-24
DK1379262T3 (da) 2005-02-14
JP2004538263A (ja) 2004-12-24
ATE278411T1 (de) 2004-10-15
CA2443302A1 (fr) 2002-10-24
FR2823116A1 (fr) 2002-10-11
HUP0303797A3 (en) 2005-05-30

Similar Documents

Publication Publication Date Title
DK1379262T3 (da) Fremgangsmåde til fremstilling af et med aktive stoffer höjt beriget ekstrakt af Ginkgo Biloba-blade
CA2031384C (en) Active component concentrates and new active component combinations from ginkgo biloba leaves, their method of preparation and pharmaceuticals containing the active component concentrates or the active component combinations
JPH05260907A (ja) 低カフェイン含量茶ポリフェノールの製造法
CA2031386A1 (en) Extract from ginkgo biloba leaves, its method of preparation and pharmaceuticals containing the extract
CN101692932B (zh) 含有茶多糖的卷烟及其制备方法
US20080050457A1 (en) Ginkgo Biloba Extract And Method For Producing The Same
CN111944165B (zh) 一种多酚类酪氨酸酶抑制剂及其提取方法和应用
CN109549880A (zh) 一种啤酒花美白提取液的制备方法
CN102711527B (zh) 茶水的制备方法以及通过该方法制得的茶水
CN103751552A (zh) 一种具有抗衰老功效的中药组合物及制备方法和应用
CN102614229A (zh) 一种从银杏叶提取物中脱除银杏酸的方法
CN108653202A (zh) 一种清眸组合物、包含其的眼液及其制备方法
CN1191678A (zh) 一种银杏茶及制作方法
KR101070708B1 (ko) 보령산 머드 추출물의 추출방법 및 그 추출물을 함유하는 미백기능성 화장료 조성물
WO2025150492A1 (ja) 抗酸化組成物
CN106924117A (zh) 用提取青蒿素后剩余的黄花蒿残渣制备的洗护用品组合物
JPH11290438A (ja) 消臭剤組成物
JPH10273444A (ja) イチョウエキスの製造方法
JPH03227985A (ja) イチョウ葉からフラボノイドを高含有する抽出物の簡易な製造法
JP2003500346A (ja) 皮膚美白剤
CN1099294C (zh) 一种银杏注射液的制备方法
JPH02193907A (ja) イチョウエキスの製法
CN105476908A (zh) 一种含有芦荟提取物、桑叶提取物和玫瑰花提取物的美白化妆品
CN106726890A (zh) 金花茶洗发液的生产方法
KR890000651B1 (ko) 은행잎으로부터 고농도의 푸라보노이드의 추출방법

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20130409